Iron trafficking in patients with Indian Post kala-azar dermal leishmaniasis

Aishwarya Dighal1, Debanjan Mukhopadhyay1, Ritika Sengupta1

  • 1Dept. of Pharmacology, Institute of Postgraduate Medical Education and Research, Kolkata, India.

Abstract

Insights

Iron levels in monocytes/macrophages are elevated in Post Kala-azar Dermal Leishmaniasis (PKDL) due to increased iron uptake, despite higher iron export. This creates a pro-parasitic environment, suggesting new therapeutic strategies to restrict iron availability to the parasite.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Trace Element Metabolism

Background:

  • Iron is crucial in infections, benefiting pathogens but also aiding host defense.
  • Its role in visceral leishmaniasis is known, but less so in Post Kala-azar Dermal Leishmaniasis (PKDL).
  • This study investigates iron status in PKDL monocytes/macrophages.

Purpose of the Study:

  • To determine the iron status within monocytes/macrophages in Post Kala-azar Dermal Leishmaniasis (PKDL) cases.
  • To understand iron transport mechanisms in PKDL lesions.
  • To identify potential therapeutic targets for PKDL.

Main Methods:

  • Flow cytometry and ELISA measured intramonocytic labile iron pool (LIP), CD163, CD71, and soluble CD163 in monocytes.
  • Prussian blue staining assessed Fe3+ in lesions; qPCR quantified parasite load.
  • Droplet digital PCR analyzed mRNA expression of iron-related genes (TfR, CD163, DMT-1, Lcn-2, HO-1, Ferritin, NRAMP-1, Fpn-1).

Main Results:

  • PKDL monocytes showed elevated CD71, CD163, and soluble CD163.
  • Lesional mRNA expression of TfR, CD163, DMT1, and Lcn-2 was increased.
  • Elevated LIP correlated with increased ferritin and HO-1 mRNA, and higher expression of iron exporters NRAMP-1 and Fpn-1.

Conclusions:

  • Increased iron influx via TfR, CD163, DMT-1, and Lcn-2 likely contributes to elevated LIP in PKDL.
  • Enhanced NRAMP-1 and Fpn-1 expression contradicts the typical macrophage phenotype, suggesting a pro-parasitic environment.
  • Targeting iron availability to parasites may offer novel PKDL treatment strategies.

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...